Reprogramming the genetic code in vitro.

Area of Science:

• Biochemistry
• Synthetic Biology
• Molecular Biology

Background:

• Genetic code reprogramming allows site-specific incorporation of non-canonical amino acids (ncAAs) into polypeptides.
• Current methods rely on tRNA mis-acylation, utilizing engineered synthetases or ribozymes.
• This technique is crucial for biochemical studies and bioorganic synthesis.

Purpose of the Study:

• To review the development and applications of in vitro genetic code reprogramming.
• To highlight enzymatic mis-acylation strategies for synthesizing non-canonical aminoacyl-tRNAs.
• To discuss advancements in engineering the translational machinery for broader ncAA incorporation.

Main Methods:

• Enzymatic mis-acylation using engineered protein or ribozyme aminoacyl-tRNA synthetases.
• In vitro synthesis of non-canonical aminoacyl-tRNAs.
• Engineering of the translational machinery to accommodate diverse ncAAs.

Main Results:

• Hundreds of different ncAAs can be incorporated into polypeptides in vitro.
• Enzymatic mis-acylation provides a versatile platform for ncAA synthesis.
• Ongoing efforts aim to expand the repertoire of translatable ncAAs.

Conclusions:

• In vitro genetic code reprogramming, particularly enzymatic mis-acylation, is a powerful tool for protein engineering.
• Further engineering of the translational machinery is key to increasing the diversity of incorporated ncAAs.
• This technology holds significant potential for biochemical research and synthetic biology applications.